Concepedia

Treatment of Perianal Fistulas in Crohn’s Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial

K Wasmann, E. Joline de Groof, M E Stellingwerf, Geert D’Haens, Cyriel Y. Ponsioen, K Gecse, Marcel G. W. Dijkgraaf, Michael F. Gerhards, Jeroen M. Jansen, Apollo Pronk,

Journal of Crohn s and Colitis · 2020 · 111 citations · 11 references

DOIFull text

Open access

Abstract

The results imply that chronic seton treatment should not be recommended as the sole treatment for perianal Crohn's fistulas.

References

11

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

Assessing the Gold Standard — Lessons from the History of RCTs

Laura E. Bothwell, Jeremy A. Greene, Scott H. Podolsky et al. · New England Journal of Medicine · 2016 · 634 citations

, , +14

Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease.

G Hellers, O Bergstrand, S Ewerth et al. · Gut · 1980 · 475 citations · Full text

, , +8

Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease

G. Van Assche, Dirk Vanbeckevoort, Didier Bielen et al. · The American Journal of Gastroenterology · 2003 · 378 citations

Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease

Gert Van Assche · The American Journal of Gastroenterology · 2003 · 314 citations

, , +6